A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Recruiting

AvacopanA Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Sponsor:

Amgen

Code:

NCT06072482

Conditions

Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Avacopan

Placebo

Standard of Care

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Amgen on 2025-04-11.